Abstracts tagged "diagnosis"

Abstract Number: 202 • 2014 ACR/ARHP Annual Meeting
Is Schuss View Alone Enough for the Diagnosis of Femorotibial Osteoarthritis ? the Khoala Cohort Study
Christian Roux¹, Bernard Mazieres², Evelyne Verrouil², Anne-Christine Rat,³, Patrice Fardellone⁴, Bruno Fautrel⁵, Jacques Pouchot⁶, Alain Saraux⁷, Francis Guillemin⁸, Liana Euller Ziegler⁹ and Joel Coste¹⁰, ¹Rhumatologie, Hopital Archet 1 - Université Nice Sophia Antipolis, Nice, France, ²CHU Toulouse, Toulouse, France, ³Université de Lorraine, Université Paris Descartes, Apemac, EA 4360, Nancy, France, ⁴Service de Rhumatologie, Hôpital Nord, C.H.U. d'Amiens, Amiens, France, ⁵CHU - Hôpital Pitié-Salpêtrière, Paris, France, ⁶Medecine Interne, Hopital Louis Mourier, Colombes, FRANCE, France, ⁷Rheumatology, CHU de la Cavale Blanche and Université Bretagne occidentale, Brest Cedex, France, ⁸INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) CIE6, Nancy, France, ⁹151 rte de St Antoine de Gines, CHU de Nice -Université Nice Sophia Antipolis, Nice, France, ¹⁰CHU Hotel Dieu, Paris, France
Background/Purpose: Associating an anteroposterior (AP) extended-knee X-ray with a semiflexed AP or posteroanterior (PA) view is considered the gold standard for radiologically diagnosing tibiofemoral osteoarthritis…
Abstract Number: 2774 • 2014 ACR/ARHP Annual Meeting
Why Leg Ulcers Do Not Heal? a Prospective Study Showing High Proportion of Small Vessel Vasculitis
Vinod Ravindran¹, Sunil Rajendran² and Ranjish Vijayan², ¹National Hospital, Kozhikode, Kerala, India, ²PVS Hospital, Kozhikode, India
Background/Purpose: Non healing cutaneous ulcers of lower limbs can have several different aetiologies [1]. It is likely that the patients with such ulcers would be…
Abstract Number: 2624 • 2014 ACR/ARHP Annual Meeting
Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
John McDougall Jr.¹, Charles G. Helmick², S. Sam Lim³, Caroline Gordon⁴ and Elizabeth Ferucci⁵, ¹Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ³Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ⁴Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁵Alaska Native Medical Center, Anchorage, AK
Background/Purpose Systemic lupus erythematosus (SLE) is a complex disease that is traditionally diagnosed and managed by specialists, typically rheumatologists. Higher SLE prevalence in racial/ethnic minorities…
Abstract Number: 2279 • 2014 ACR/ARHP Annual Meeting
Evidence Based Recommendations for Diagnosis and Management of Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS)
Nienke ter Haar¹, Paul Brogan², Gilles Grateau³, Jordi Anton⁴, Karyl Barron⁵, Luca Cantarini⁶, Joost Frenkel⁷, Caroline Galeotti⁸, Veronique Hentgen⁹, Michael Hofer¹⁰, Tilmann Kallinich¹¹, Isabelle Kone-Paut¹², Jasmin Kuemmerle-Deschner¹³, Huri Ozdogan¹⁴, Seza Ozen¹⁵, Ricardo Russo¹⁶, Anna Simon¹⁷, Yosef Uziel¹⁸, Carine Wouters¹⁹, Brian Feldman²⁰, Bas Vastert⁷, Nico Wulffraat²¹, Helen Lachmann²² and Marco Gattorno²³, ¹Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ²Rheumatology Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ³Service De Médecine Interne, Hopital Tenon, Paris, France, ⁴Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, ⁵NIH, Bethesda, MD, ⁶University of Siena, Siena, Italy, ⁷University Medical Center Utrecht, Utrecht, Netherlands, ⁸Bicêtre Hospital, University of Paris SUD, Paris, France, ⁹Versailles Hospital, Le Chesnay Cedex, France, ¹⁰Centre Multisite Romand de Rhumatologie Pediatrique, Lausanne, Switzerland, ¹¹Charite, University Medicine Berlin, Berlin, Germany, ¹²Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France, ¹³Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, ¹⁴Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ¹⁵Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, ¹⁶Immunology & Rheumatology, Hospital De Pediatria, Buenos Aires, Argentina, ¹⁷Radboudumc, Nijmegen, Netherlands, ¹⁸Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, ¹⁹University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, ²⁰Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ²¹Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, ²²UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom, ²³Istituto Giannina Gaslini, Genova, Italy
Background/Purpose Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) is a rare hereditary autoinflammatory syndrome that can lead to significant morbidity. Evidence-based guidelines are lacking…
Abstract Number: 2585 • 2013 ACR/ARHP Annual Meeting
Left Ventricular Dysfunction Reflected By Higher Serum Brain Natriuretic Peptide Accounts For Poorer Prognosis Of Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Sumiaki Tanaka¹, Yoshiyuki Arinuma¹, Tatsuhiko Wada¹, Tatsuo Nagai², Jun Okada³ and Shunsei Hirohata¹, ¹Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan, ²Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan, ³Nutritional management, Kitasato Junior Collage of health and Hygienic Sciences, Minami-Uonuma, Japan
Background/Purpose: Recentry, development of potent effective newer drugs for pulmonary arterial hypertension (PAH) have resulted in improving survival of the patients. However, the prognosis of…
Abstract Number: 2519 • 2013 ACR/ARHP Annual Meeting
A Systemic Lupus Erythematosus (SLE) Diagnostic Test Based On DNA Methylation Signatures From Peripheral Blood Mononuclear Cells
David W. Anderson¹, Robert Shoemaker², Kurt Krummel³, Zachary Hornby⁴ and Jonathan E. Lim¹, ¹Research and Development, IGNYTA, Inc., San Diego, CA, ²Bioinformatics, IGNYTA, Inc., San Diego, CA, ³Research and Development-Assay Development, IGNYTA, Inc., San Diego, CA, ⁴Business Development, IGNYTA, Inc., San Diego, CA
Background/Purpose: The heterogeneous nature of SLE and a lack of reliable biomarkers make SLE a challenge to classify in patients. A differential diagnosis of SLE…
Abstract Number: 2288 • 2013 ACR/ARHP Annual Meeting
Novel Biomarkers From Peripheral Blood Mononuclear Cells Indicate Disease Activity In Rheumatoid Arthritis Patients
Jason Ptacek¹, Rachael Hawtin², Brent Louie¹, Erik Evensen¹, James Cordeiro¹, Barbara Mittleman¹, Michelle Atallah¹, Alessandra Cesano², Clifton O. Bingham III³, Stacey Cofield⁴, Jeffrey R. Curtis⁵, Maria I. Danila⁴, Richard A. Furie⁶, MC Genovese⁷, Marc C. Levesque⁸, Larry W. Moreland⁸, Peter A. Nigrovic⁹, James R. O'Dell¹⁰, William H. Robinson¹¹, Nancy A. Shadick⁹, E. William St Clair¹², Christopher C. Striebich¹³, Geoffrey M Thiele¹⁴, Peter K. Gregersen⁶ and S. Louis Bridges Jr.⁴, ¹Nodality, Inc., South San Francisco, CA, ²Nodality Inc., South San Francisco, CA, ³Rheumatology, Johns Hopkins University, Baltimore, MD, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵Epidemiology, University of Alabama at Birmingham, School of Public Health, Birmingham, AL, ⁶The Feinstein Institute for Medical Research and North Shore-Long Island Jewish Health System, Lake Success, NY, ⁷Stanford University, Palo Alto, CA, ⁸University of Pittsburgh, Pittsburgh, PA, ⁹Brigham and Women's Hospital/Harvard University, Cambridge, MA, ¹⁰Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, ¹¹VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, ¹²Medicine, Duke Unversity Medical Center, Durham, NC, ¹³University of Colorado Denver, Aurora, CO, ¹⁴Omaha VA and the University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Biomarkers reflecting immune function and associating with disease activity can help stratify rheumatoid arthritis (RA) patients (pts) in practice and in clinical trials.…
Abstract Number: 2160 • 2013 ACR/ARHP Annual Meeting
The Journey to Diagnosis in As/Axial Spondyloarthritis – the Psychological Impact of Delay
Jane Martindale^1,2 and Lynne Goodacre², ¹Physiotherapy, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan, United Kingdom, ²Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
Background/Purpose: It is not uncommon for 8 to 11 years to pass between symptoms onset and definitive diagnosis of AS/axial SpA (Gran 1997, Feldtkeller, 2003).…
Abstract Number: 2025 • 2013 ACR/ARHP Annual Meeting
Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Yoshinobu Koyama¹, Motohiko Tanino², Hirokazu Shiraishi³, Shuji Nagano⁴, Toshiyuki Ota⁴ and Toshie Higuchi⁵, ¹Division of Rheumatology, Okayama Red Cross General Hospital, Okayama, Japan, ²DNA Chip Research Inc., Yokohama, Japan, ³Orthopedics, Iizuka Hospital, Iizuka, Japan, ⁴Center for Rheumatic Diseases, Iizuka Hospital, Iizuka, Japan, ⁵Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan
Background/Purpose: There are many clinical similarities between polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA). It has been reported that the specificity for discriminating PMR from…
Abstract Number: 838 • 2013 ACR/ARHP Annual Meeting
Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided By Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents
Mary-Ann Fitzcharles¹, Yoram Shir², Jacob N. Ablin³, Dan Buskila⁴, Howard Amital⁵, Peter Henningsen⁶ and Winfried Häuser⁷, ¹Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ²Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ³Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ⁴Ben-Gurion University, Beer-Sheva, Israel, ⁵Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, ⁶Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, ⁷Klinikum Saarbrücken, Saarbrücken, Germany
Background/Purpose: Fibromyalgia (FM), often disputed and challenged, has emerged as a clear cluster of symptoms and co-morbidities, characterized by subjective complaints without physical or biomarker…
Abstract Number: 826 • 2013 ACR/ARHP Annual Meeting
The Value Of History and Physical Examination Findings In The Diagnosis Of Symptomatic Meniscal Tear Among Middle-Age Subjects With Knee Pain
Jeffrey N. Katz¹, Yan Dong², John Wright³, Stephanie Chen⁴, Scott Martin⁵, Laurel Donnell-Fink⁵, Benjamin N. Rome² and Elena Losina², ¹Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ²Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, ⁴Orthopedics and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ⁵Brigham and Women's Hospital, Boston, MA
Background/Purpose: Clinicians often rely on mechanical symptoms (e.g. clicking, catching, popping, giving way) and tests such as the McMurray sign in the diagnosis of symptomatic…
Abstract Number: 690 • 2013 ACR/ARHP Annual Meeting
Assessment Of The New American and European Classification Criteria For Systemic Sclerosis In The Norwegian Systemic Connective Tissue Disease and Vasculitis Registry
Anna-Maria Hoffmann-Vold¹, Torhild Garen², Oyvind Midtvedt¹ and Øyvind Molberg³, ¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ³Oslo University Hospital, Oslo, Norway
Background/Purpose: To assess the newly established ACR/EULAR classification criteria for systemic sclerosis 1 (SSc) in a large Norwegian SSc registry cohort. Methods: The Norwegian systemic…
Abstract Number: 524 • 2013 ACR/ARHP Annual Meeting
Expansion Of DC-STAMP⁺ IL-17⁺ Cells In Bone Marrow From Psoriasis and Psoriatic Arthritis Patients
Yahui Grace Chiu¹, Edward M. Schwarz², Jamie Biear¹, Debbie Campbell³, Jennifer Hossler¹, Jennifer H. Anolik⁴, R. John Looney¹ and Christopher T. Ritchlin¹, ¹Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, ²Center for Musculoskeletal Research, University of Rochester, Rochester, NY, ³Allergy, Immunology and Rheumatology, Univerity of Rochester, Rochester, NY, ⁴Medicine- Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY
Background/Purpose: Focal erosions in inflammatory arthritis are mediated by bone marrow (BM) derived osteoclasts (OC) that enter the joint as OC precursors (OCP) from peripheral…
Abstract Number: 510 • 2013 ACR/ARHP Annual Meeting
Multicentric Analysis Of Inter and Intra Observer Reliabilities For Histopathological Abnormalities In Salivary Gland Biopsy In Primary Sjögren Syndrome
Sebastian Costa¹, Isabelle Quintin Roue², Agnes Lesourd², Sandrine Jousse-Joulin³, Pascale Marcorelles⁴, Eric Hachulla⁵, Vincent Goeb⁶, Marie-Christine Copin⁷, Jean-Marie Berthelot⁸, Jacques-Olivier Pers⁹, Olivier Vittecoq¹⁰, Emmanuel Nowak¹¹, Alain Saraux¹² and Valerie Devauchelle-Pensec¹³, ¹anatomopathological department, Brest university hospital, Brest, France, ²anatomopathological department, Morvan hospital, Brest, France, ³Rheumatology, Brest university medical school, EA 2216, UBO and CHU de la Cavale Blanche,, Brest, France, ⁴anatomopathological department, Brest university hospital, CHU Morvan, Brest, France, ⁵Internal Medicine, Lille CEDEX, France, ⁶Rheumatology, Amiens University Hospital, Amiens, France, ⁷anatomopathological department, Lille university, Lille, France, ⁸Rheumatology Unit, Nantes University Hospital, Nantes, France, ⁹Unit of immunology, EA 2216, Brest Occidentale University, Brest, France, ¹⁰Rheumatology, Rouen University Hospital & Inserm905, University of Rouen, Rouen Cedex, France, ¹¹CIC, CHU Brest, Brest, France, ¹²Department of rheumatology and unit of immunology (EA 2216), Université Brest Occidentale, Brest, France, ¹³Department of rheumatology and unit of immunology (EA2216), Brest Occidentale university, Brest, France
Background/Purpose: : Histopathologic evaluation of minor labial salivary gland (MLSG) is a major goal for the classification of patients with a primary Sjögren syndrome (pSS)…
Abstract Number: 309 • 2013 ACR/ARHP Annual Meeting
Diagnostic Delay Of Even More Than 6 Months Contributes To Poor Radiographic and Functional Outcome In Psoriatic Arthritis
Muhammad Haroon¹, Phil Gallagher² and Oliver FitzGerald¹, ¹Department of Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, ²Rheumatology, St. Vincent's University Hospital, Dublin, Ireland
Background/Purpose: Diagnostic delay in Psoriatic Arthritis (PsA) is not uncommon with a recent study of psoriasis patients attending a dermatology clinic showing that 29% of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].